Comments on the “Prognostic Impact and Clinicopathological Correlation of CD133 and ALDH1 Expression in Invasive Breast Cancer”

참고문헌 (Reference)

1 Kapucuoğlu N, "The clinicopathological and prognostic significance of CD24, CD44, CD133, ALDH1 expressions in invasive ductal carcinoma of the breast: CD44/CD24 expression in breast cancer" 211 : 740-747, 2015

2 Collina F, "Prognostic value of cancer stem cells markers in triplenegative breast cancer" 2015 : 158682-, 2015

3 Ieni A, "Prognostic impact of CD133immunoexpression in node-negative invasive breast carcinomas" 31 : 1315-1320, 2011

4 김성집, "Prognostic Impact and Clinicopathological Correlation of CD133 and ALDH1 Expression in Invasive Breast Cancer" 한국유방암학회 18 (18): 347-355, 2015

5 Zhang M, "Nestin and CD133: valuable stem cell-specific markers for determining clinical outcome of glioma patients" 27 : 85-, 2008

6 Han Z, "Clinicopathological significance of CD133 and CD44 expression in infiltrating ductal carcinoma and their relationship to angiogenesis" 13 : 56-, 2015

7 Mansour SF, "Clinicopathological significance of CD133 and ALDH1 cancer stem cell marker expression in invasive ductal breast carcinoma" 16 : 7491-7496, 2015

8 Zhao P, "Clinicopathological significance and prognostic value of CD133 expression in triple-negative breast carcinoma" 102 : 1107-1111, 2011

9 Croker AK, "Cancer stem cells: implications for the progression and treatment of metastatic disease" 12 : 374-390, 2008

10 Tsang JY, "Cancer stem cell markers are associated with adverse biomarker profiles and molecular subtypes of breast cancer" 136 : 407-417, 2012

11 Aomatsu N, "CD133 is a useful surrogate marker for predicting chemosensitivity to neoadjuvant chemotherapy in breast cancer" 7 : e45865-, 2012

12 Chuthapisith S, "Breast cancer chemoresistance:emerging importance of cancer stem cells" 19 : 27-32, 2010

13 Ginestier C, "ALDH1 is a marker of normal and malignant human mammary stem cells and a predictor of poor clinical outcome" 1 : 555-567, 2007